Quantcast
Last updated on April 18, 2014 at 1:21 EDT

Latest Drug-eluting stent Stories

2014-03-05 12:27:46

-- Rapid polymer absorption within three months coupled with drug delivery profile up to nine months provides for excellent healing -- DURHAM, N.C., March 5, 2014 /PRNewswire/ --- Micell Technologies, Inc. today announced that the long-term clinical outcomes from the DESSOLVE I and II clinical trials recently were presented at the Cardiovascular Research Technologies (CRT) Conference held in Washington, D.C., February 22 - 25. The data presentation, "MiStent SES Clinical Program:...

2014-02-26 04:21:30

Company Initiates Joint U.S. and Japanese Registration Trial HONG KONG, Feb. 26, 2014 /PRNewswire/ -- OrbusNeich today announced that patient enrollment has been initiated in Japan in the pivotal clinical trial of the COMBO Dual Therapy Stent(TM) (COMBO Stent) employing a single Japan-U.S. protocol conducted as a Global Clinical Trial "proof-of-concept" under the framework of the joint Japan-U.S. Harmonization-By-Doing [HBD] initiative. The first patient was enrolled at Shonan...

2014-02-21 23:04:31

The current issue of the Journal of Endovascular Therapy offers results of a prospective study seeking to establish the rate of 1-year restenosis in diabetic patients with femoropopliteal in-stent restenosis who underwent treatment with drug-eluting balloon angioplasty. Lawrence, Kansas (PRWEB) February 21, 2014 Despite good immediate results, in up to 40 percent of patients, obstructed arteries in the leg treated with a stent will again become blocked. This in-stent restenosis is...

2014-02-13 12:27:49

LONDON, Feb. 13, 2014 PRNewswire/ -- Reportbuyer.com just published a new market research report:China Interventional Cardiovascular Device Industry Report, 2013-2015 With the accelerated aging, the prevalence of cardiovascular diseases in China increased year by year. According to statistics of National Health and Family Planning Commission of the People's Republic of China, in 2012 cardiovascular disease deaths in China reached 3.5 million. The fast growing number of heart patients...

2014-02-13 12:26:58

Aortic Stent Grafts Will Continue To Generate the Majority of Revenues Due To Strong Acceptance in the Thoracic Indication, According to Decision Research Group BURLINGTON, Mass., Feb. 13, 2014 /PRNewswire/ -- Decision Resources Group finds that the Chinese peripheral vascular (PV) device market will grow strongly through 2022 as patients in China increasingly seek treatment for PV disease. Historically, awareness of the disease among patients and physicians was low, resulting in a...

2014-02-06 23:21:59

Transparency Market Research Report published "Drug Device Combination Products Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" to its database. Browse the full report with TOC at http://www.transparencymarketresearch.com/drug-device-combination.html. Albany, New York, USA (PRWEB) February 06, 2014 This report studies the global market for drug device combination products from the perspective of product types. The market is thus...

2014-01-28 20:22:25

DUBLIN, Ireland, January 28, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/fvxjv3/cardiovascular) has announced the addition of a new report "Global Cardiovascular Drug Delivery Market" [http://www.researchandmarkets.com/research/fvxjv3/cardiovascular ] to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Drug delivery to the cardiovascular system is different from delivery to other systems because...

2014-01-20 12:25:09

LONDON, Jan. 20, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Medical Devices Industry and Market Prospects 2013-2023 Report Details Medical devices - your guide to developments, opportunities, and revenuesWhat does the future hold for medical devices? Visiongain's report shows you potential revenues to 2023, assessing data, trends, opportunities and prospects in this market. Our study gives you revenue forecasts to 2023 at overall world market...

2014-01-20 12:24:40

LONDON, Jan. 20, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: MediPoint: Drug-Eluting Balloons - EU Analysis and Market Forecasts MediPoint: Drug-Eluting Balloons - EU Analysis and Market Forecasts Summary GlobalData has released its medical devices report, "MediPoint: Drug-Eluting Balloons - EU Analysis and Market Forecasts". The report provides in-depth insight into the use of DEB in the European Union (EU) for coronary and peripheral...

2014-01-20 08:22:43

SUNNYVALE, Calif., Jan. 20, 2014 /PRNewswire/ -- Cardiva Medical, Inc. announced today that Randy Hubbell has been appointed Chief Commercial Officer. He will be responsible for expanding commercialization efforts for Cardiva's portfolio of devices for femoral vascular closure including the VASCADE® Vascular Closure System and the Catalyst® closure wire. "Randy brings to Cardiva a unique blend of commercial expertise and strategic marketing that will prove invaluable to...